Skip to main content
Caplight Logo









Clexio Biosciences

Clexio Biosciences

Private
IsraelHealthcare & Life Scienceshttps://www.clexio.com/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Clexio Biosciences is a clinical-stage pharmaceutical company that develops novel drugs and drug-device combinations for the treatment of neurological and psychiatric conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discoverysmall molecule therapeuticscentral nervous systemCNSneurological disorderspsychiatric disordersclinical trialsbiotechdrug developmentclinical-stagemental healthpharma pipelineneuroscience

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Clexio Biosciences Comparables

Compare Clexio Biosciences with similar companies based on industry and business-model similarity.

Clexio Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Evecxia Therapeutics
82%
MapLight Therapeutics
76%
Addex Therapeutics
74%

Clexio Biosciences Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Menashe Levy

Co-founder and CTO

Founding Team

Elisabeth Kogan

CEO And Co-founder At Syremis Therapeutics

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 49% MoM, reaching 3.6K.

  • Jan 5, 2026

    Monthly visitors increased 65% MoM.

Clexio Biosciences Filings

Explore SEC and related filing metadata, where available.

Clexio Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Clexio Biosciences's valuation, stock price, and market status.

Is Clexio Biosciences a public or private company?

Clexio Biosciences is a private company.

What is the current stock price of Clexio Biosciences?

Clexio Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Clexio Biosciences worth (valuation)?

Valuation information for Clexio Biosciences is not publicly available.

Can I buy Clexio Biosciences stock?

Clexio Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Clexio Biosciences's last funding round?

Funding round information for Clexio Biosciences is not publicly available.

Who are the main investors in Clexio Biosciences?

Investor information for Clexio Biosciences is not publicly disclosed.

Will Clexio Biosciences IPO soon?

No public IPO plans have been announced for Clexio Biosciences.

How can I track Clexio Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clexio Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range28
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?